[1] ZHU C,SHEN S,ZHANG S,et al.Autophagy in bone remodeling:A regulator of oxidative stress[J].Frontiers in Endocrinology,2022,13:898634. [2] HAMMOUDA M B,FORD A E,LIU Y,et al.The JNK signaling pathway in inflammatory skin disorders and cancer[J].Cells,2020,9(4):857. [3] LE A,AZOUZ A,THOMAS S,et al.JNK1 signaling downstream of the egfr pathway contributes to aldara((r))-induced skin inflammation[J].Frontiers in Immunology,2020,11:604785. [4] VENTURA J J,KENNEDY N J,LAMB J A,et al.c-Jun BH2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor[J].Molecular and Cellular Biology,2003,23(8):2871-2882. [5] SUNDARRAJAN M,BOYLE D L,CHABAUD-RIOU M,et al.Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK[J].Arthritis & Rheumatology,2003,48(9):2450-2460. [6] SMITH T,LIN X,MELLO M,et al.Peripheral deletion of CD8 T cells requires p38 MAPK in cross-presenting dendritic cells[J].The Journal of Immunology,2017,199(8):2713-2720. [7] TORII S,YAMAMOTO T,TSUCHIYA Y,et al.ERK map kinase in G1 cell cycle progression and cancer[J].Cancer Science,2006,97(8):697-702. [8] ANFINOGENOVA N D,QUINN M T,SCHEPETKIN I A,et al.Alarmins and c-Jun N-terminal kinase (JNK) signaling in neuroinflammation[J].Cells,2020,9(11):2350. [9] YUNG J H M,GIACCA A.Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes[J].Cells,2020,9(3):706. [10] WU Q,WU W,FU B,et al.JNK signaling in cancer cell survival[J].Medicinal Research Reviews,2019,39(6):2082-2104. [11] CHENG Y,CHEN J,SHI Y,et al.MAPK signaling pathway in oral squamous cell carcinoma:Biological function and targeted therapy[J].Cancers,2022,14(19):4625. [12] LIU X,LI L,BAI J,et al.Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3/MAPK8 signaling[J].Cancer Science,2022,113(1):109-119. [13] CHENG Y,ZHONG X,NIE X,et al.Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling[J].Phytomedicine,2023,114:154757. [14] YANEZ-GOMEZ F,RAMOS-MIGUEL A,GARCIA-SEVILLA J A,et al.Regulation of cortico-thalamic JNK1/2 and ERK1/2 MAPKs and apoptosis-related signaling pathways in PDYN gene-deficient mice following acute and chronic mild stress[J].International Journal of Molecular Sciences,2023,24(3):2303. [15] ZHANG D,WANG G,QIN L,et al.Restoring mammary gland structures and functions with autogenous cell therapy[J].Biomaterials,2021,277:121075. [16] JUN S,LEE S,KIM H C,et al.Paf-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis[J].Cell Reports,2013,5(2):314-322. [17] WANG Y,BI Y,ZUO Q,et al.MAPK8 regulates chicken male germ cell differentiation through JNK signaling pathway[J].Journal of Cellular Biochemistry,2018,119(2):1548-1557. [18] HONG L,XU D,LI W,et al.Non-coding RNA regulation of Magang geese skeletal muscle maturation via the MAPK signaling pathway[J].Frontiers in Physiology,2023,14:1331974. [19] 刘慧旭.JNK1和JNK2过表达对人皮肤鳞状细胞癌SCL-1细胞增殖及凋亡的影响[D].银川:宁夏医科大学,2019.LIU H X.Effects of overexpression of JNK1 and JNK2 on proliferation and apoptosis of human squamous cell carcinoma cell lines SCL-1[D].Yinchuan:Ningxia Medical University,2019.(in Chinese) [20] TU H,XIONG W,ZHANG J,et al.Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation[J].Nature Communications,2022,13(1):6603. [21] JOHNSON J L,YARON T M,HUNTSMAN E M,et al.An atlas of substrate specificities for the human serine/threonine kinome[J].Nature,2023,613(7945):759-766. [22] KLIONSKY D J,PETRONI G,AMARAVADI R K,et al.Autophagy in major human diseases[J].The European Molecular Biology Organization Journal,2021,40(19):e108863. [23] HAMMOUDA M B,FORD A E,LIU Y.The JNK signaling pathway in inflammatory skin disorders and cancer[J].Cells,2020,9(4):857. [24] ODAKA T,SAKAMOTO R,KUMAGAI K,et al.Ephrin type-A receptor 2-antisense RNA1/2 promote proliferation and migration of MDA-MB-231 cells through EPHA2-dependent ras signaling pathway mediated by MAPK8/JNK1,MAPK9/JNK2-NFATC2/NFAT1 and JUND[J].Frontiers in Molecular Biosciences,2024,11:1402354. [25] KHARKWAL G,CHANDRA V,FATIMA I.Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells[J].Journal of Molecular Endocrinology,2012,48(3):261-270. [26] BULCHA J T,WANG Y,MA H,et al.Viral vector platforms within the gene therapy landscape[J].Signal Transduction and Targeted Therapy,2021,6(1):53. |